Arcadia Biosciences shares are trading higher after the company reported a year-over-year increase in its Q2 EPS results.benzinga_article·Aug 13 at 03:29 PMRKDA+0.75%
Arcadia Biosciences gets Nasdaq notice for failing $1 minimum bid price rulePUBT·Aug 10 at 05:05 AMRKDA+0.75%
Arcadia Biosciences awards CEO Thomas Schaefer $169,000 discretionary cash bonus for 2025PUBT·Jul 2 at 03:22 PMRKDA+0.75%
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules | RKDA Stock NewsStockTitan·Jun 12 at 01:00 PMRKDA+0.75%
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules | RKDA Stock NewsStockTitan·Jun 11 at 11:00 AMRKDA+0.75%